Skip to content
healthcare.dev

Doxazosin

NDC 68071-4273, Doxazosin, tablet, from NuCare Pharmaceuticals,Inc..

Product NDC
68071-4273
Status
Listed
Labeler
NuCare Pharmaceuticals,Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68071-4273 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
68071-4273-36807142730330 TABLET in 1 BOTTLE (68071-4273-3)
68071-4273-66807142730660 TABLET in 1 BOTTLE (68071-4273-6)
68071-4273-96807142730990 TABLET in 1 BOTTLE (68071-4273-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/64a19cb1-79fc-8b0b-e053-2a91aa0aaa94

Use it

Look up 68071-4273 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68071-4273 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68071-4273. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.